Quitting the smoke is the desire of many. Research studies state that among the desirers of smoking only 5 percent are able to quit the smoking. Good news for all of you, clinical trials are being conducted on the nicotine vaccine with the group including healthy smokers and non smokers. The positive results of the clinical trial will bring the new vaccine in to the medical world. The newly arrived nicotine vaccine will control the nicotine molecules in the body from reaching the brain. This will show effective results in reducing some effects of smokers carve like appetite suppression, increased focus, and calming.
The immune system will treat the nanaoparticles released by the vaccine as the foreign invaders and prevent the nicotine from reaching the brain. The success of the clinical trial would encourage the research to treat other addictives.
No comments:
Post a Comment